IPO Stock Apogee Rockets On Solid Phase 1 Outcome Recent IPO stock Apogee Therapeutics (APGE) spiked for a second day early Tuesday after the biotech company reported some fourth-quarter financials, as well as strong interim results from an inflammatory disease treatment.